Singapore: Industrial Production disappointed in July

Senior Economist at UOB Group Alvin Liew comments on the latest Industrial Production figures in Singapore.

Key Takeaways

“Singapore’s industrial production (IP) came in below expectations for the second month in a row as it declined by -2.3% m/m SA in Jul, which translated to a weaker growth of 0.6% y/y, matching the low print recorded in Jan 2022 (from the revised Jun readings of -8.0% m/m, 2.6% y/y) and fell short of Bloomberg survey estimates but perhaps closer to UOB’s internal estimates.”

“The weaker IP result for Jul was due to 6.3% y/y contraction in electronics output and a 25.7% y/y fall in pharmaceutical production while the main sources of IP growth were from the continued expansions in transport engineering (18.6% y/y), general manufacturing (14.6% y/y), and precision engineering (13.9% y/y), and a surprise rebound in chemicals (5.3% y/y), more than offsetting the drags from electronics and pharmaceuticals.”

“Accounting for the Jul’s increase, Singapore’s IP expanded 4.9% in the first seven months of 2022. We continue to be cautiously positive on the outlook for transport engineering, general manufacturing, and precision engineering, to drive overall IP growth but we are now also cognizant about a potentially much slower electronics performance in the remaining months of 2022. We maintain our IP growth forecast at 4.5% in 2022 (from 13.2% in 2021) but we note the increased risk of a weaker IP trajectory due to the faltering outlook for electronics. In the same vein, our full year 2022 and 2023 GDP growth forecasts are also unchanged at 3.5% and 2% respectively but the manufacturing outlook indicates the risk to our growth outlook is on the downside, as well. In addition, another dampener to headline growth is the relatively higher base levels for the rest of 2022, as IP expanded by double digit growth rates between May and Dec 2021 (except for Sep 2021).”

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.